0.017599
0.000000
0.000000
0.000000
0.016445
0.000000
0.000000
0.000000
0.029542
0.00000
0.00000
0.00000
Inaka, K.
Matsushima, M.
Herning, T.
Kuroki, R.
Yutani, K.
Kikuchi, M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
90.00
90.00
56.820
60.810
33.850
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
31
7077
7085
10.1021/bi00146a008
1643041
Role of proline residues in human lysozyme stability: a scanning calorimetric study combined with X-ray structure analysis of proline mutants.
1992
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
266
20666
Crystal Structures of the Apo-and Holomutant Human Lysozymes with an Introduced Ca Binding Site
1991
US
Biochemistry
BICHAW
0033
0006-2960
30
9882
Effects of Proline Mutations on the Unfolding and Refolding of Human Lysozyme: The Slow Refolding Kinetic Phase Does not Result from Proline Cis-Trans Isomerization
1991
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
x-ray
1
1.0
14718.676
HUMAN LYSOZYME
3.2.1.17
1
man
polymer
18.015
water
101
nat
water
no
no
KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLS
CSALLQDNIADAVACAKRVVRDPQGIRAWPAWRNRCQNRDVRQYVQGCGV
KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLS
CSALLQDNIADAVACAKRVVRDPQGIRAWPAWRNRCQNRDVRQYVQGCGV
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
1.99
38.07
pdbx_database_status
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1994-01-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1992-03-27
REL
HOH
water
HOH
131
2
HOH
HOH
131
A
HOH
132
2
HOH
HOH
132
A
HOH
133
2
HOH
HOH
133
A
HOH
134
2
HOH
HOH
134
A
HOH
135
2
HOH
HOH
135
A
HOH
136
2
HOH
HOH
136
A
HOH
137
2
HOH
HOH
137
A
HOH
138
2
HOH
HOH
138
A
HOH
139
2
HOH
HOH
139
A
HOH
140
2
HOH
HOH
140
A
HOH
141
2
HOH
HOH
141
A
HOH
142
2
HOH
HOH
142
A
HOH
143
2
HOH
HOH
143
A
HOH
144
2
HOH
HOH
144
A
HOH
145
2
HOH
HOH
145
A
HOH
146
2
HOH
HOH
146
A
HOH
147
2
HOH
HOH
147
A
HOH
148
2
HOH
HOH
148
A
HOH
149
2
HOH
HOH
149
A
HOH
150
2
HOH
HOH
150
A
HOH
151
2
HOH
HOH
151
A
HOH
152
2
HOH
HOH
152
A
HOH
153
2
HOH
HOH
153
A
HOH
154
2
HOH
HOH
154
A
HOH
155
2
HOH
HOH
155
A
HOH
156
2
HOH
HOH
156
A
HOH
157
2
HOH
HOH
157
A
HOH
158
2
HOH
HOH
158
A
HOH
159
2
HOH
HOH
159
A
HOH
160
2
HOH
HOH
160
A
HOH
161
2
HOH
HOH
161
A
HOH
162
2
HOH
HOH
162
A
HOH
163
2
HOH
HOH
163
A
HOH
164
2
HOH
HOH
164
A
HOH
165
2
HOH
HOH
165
A
HOH
166
2
HOH
HOH
166
A
HOH
167
2
HOH
HOH
167
A
HOH
168
2
HOH
HOH
168
A
HOH
169
2
HOH
HOH
169
A
HOH
170
2
HOH
HOH
170
A
HOH
171
2
HOH
HOH
171
A
HOH
172
2
HOH
HOH
172
A
HOH
173
2
HOH
HOH
173
A
HOH
174
2
HOH
HOH
174
A
HOH
175
2
HOH
HOH
175
A
HOH
176
2
HOH
HOH
176
A
HOH
177
2
HOH
HOH
177
A
HOH
178
2
HOH
HOH
178
A
HOH
179
2
HOH
HOH
179
A
HOH
180
2
HOH
HOH
180
A
HOH
181
2
HOH
HOH
181
A
HOH
182
2
HOH
HOH
182
A
HOH
183
2
HOH
HOH
183
A
HOH
184
2
HOH
HOH
184
A
HOH
185
2
HOH
HOH
185
A
HOH
186
2
HOH
HOH
186
A
HOH
187
2
HOH
HOH
187
A
HOH
188
2
HOH
HOH
188
A
HOH
189
2
HOH
HOH
189
A
HOH
190
2
HOH
HOH
190
A
HOH
191
2
HOH
HOH
191
A
HOH
192
2
HOH
HOH
192
A
HOH
193
2
HOH
HOH
193
A
HOH
194
2
HOH
HOH
194
A
HOH
195
2
HOH
HOH
195
A
HOH
196
2
HOH
HOH
196
A
HOH
197
2
HOH
HOH
197
A
HOH
198
2
HOH
HOH
198
A
HOH
199
2
HOH
HOH
199
A
HOH
200
2
HOH
HOH
200
A
HOH
201
2
HOH
HOH
201
A
HOH
202
2
HOH
HOH
202
A
HOH
203
2
HOH
HOH
203
A
HOH
204
2
HOH
HOH
204
A
HOH
205
2
HOH
HOH
205
A
HOH
206
2
HOH
HOH
206
A
HOH
207
2
HOH
HOH
207
A
HOH
208
2
HOH
HOH
208
A
HOH
209
2
HOH
HOH
209
A
HOH
210
2
HOH
HOH
210
A
HOH
211
2
HOH
HOH
211
A
HOH
212
2
HOH
HOH
212
A
HOH
213
2
HOH
HOH
213
A
HOH
214
2
HOH
HOH
214
A
HOH
215
2
HOH
HOH
215
A
HOH
216
2
HOH
HOH
216
A
HOH
217
2
HOH
HOH
217
A
HOH
218
2
HOH
HOH
218
A
HOH
219
2
HOH
HOH
219
A
HOH
220
2
HOH
HOH
220
A
HOH
221
2
HOH
HOH
221
A
HOH
222
2
HOH
HOH
222
A
HOH
223
2
HOH
HOH
223
A
HOH
224
2
HOH
HOH
224
A
HOH
225
2
HOH
HOH
225
A
HOH
226
2
HOH
HOH
226
A
HOH
227
2
HOH
HOH
227
A
HOH
228
2
HOH
HOH
228
A
HOH
229
2
HOH
HOH
229
A
HOH
230
2
HOH
HOH
230
A
HOH
231
2
HOH
HOH
231
A
LYS
1
n
1
LYS
1
A
VAL
2
n
2
VAL
2
A
PHE
3
n
3
PHE
3
A
GLU
4
n
4
GLU
4
A
ARG
5
n
5
ARG
5
A
CYS
6
n
6
CYS
6
A
GLU
7
n
7
GLU
7
A
LEU
8
n
8
LEU
8
A
ALA
9
n
9
ALA
9
A
ARG
10
n
10
ARG
10
A
THR
11
n
11
THR
11
A
LEU
12
n
12
LEU
12
A
LYS
13
n
13
LYS
13
A
ARG
14
n
14
ARG
14
A
LEU
15
n
15
LEU
15
A
GLY
16
n
16
GLY
16
A
MET
17
n
17
MET
17
A
ASP
18
n
18
ASP
18
A
GLY
19
n
19
GLY
19
A
TYR
20
n
20
TYR
20
A
ARG
21
n
21
ARG
21
A
GLY
22
n
22
GLY
22
A
ILE
23
n
23
ILE
23
A
SER
24
n
24
SER
24
A
LEU
25
n
25
LEU
25
A
ALA
26
n
26
ALA
26
A
ASN
27
n
27
ASN
27
A
TRP
28
n
28
TRP
28
A
MET
29
n
29
MET
29
A
CYS
30
n
30
CYS
30
A
LEU
31
n
31
LEU
31
A
ALA
32
n
32
ALA
32
A
LYS
33
n
33
LYS
33
A
TRP
34
n
34
TRP
34
A
GLU
35
n
35
GLU
35
A
SER
36
n
36
SER
36
A
GLY
37
n
37
GLY
37
A
TYR
38
n
38
TYR
38
A
ASN
39
n
39
ASN
39
A
THR
40
n
40
THR
40
A
ARG
41
n
41
ARG
41
A
ALA
42
n
42
ALA
42
A
THR
43
n
43
THR
43
A
ASN
44
n
44
ASN
44
A
TYR
45
n
45
TYR
45
A
ASN
46
n
46
ASN
46
A
ALA
47
n
47
ALA
47
A
GLY
48
n
48
GLY
48
A
ASP
49
n
49
ASP
49
A
ARG
50
n
50
ARG
50
A
SER
51
n
51
SER
51
A
THR
52
n
52
THR
52
A
ASP
53
n
53
ASP
53
A
TYR
54
n
54
TYR
54
A
GLY
55
n
55
GLY
55
A
ILE
56
n
56
ILE
56
A
PHE
57
n
57
PHE
57
A
GLN
58
n
58
GLN
58
A
ILE
59
n
59
ILE
59
A
ASN
60
n
60
ASN
60
A
SER
61
n
61
SER
61
A
ARG
62
n
62
ARG
62
A
TYR
63
n
63
TYR
63
A
TRP
64
n
64
TRP
64
A
CYS
65
n
65
CYS
65
A
ASN
66
n
66
ASN
66
A
ASP
67
n
67
ASP
67
A
GLY
68
n
68
GLY
68
A
LYS
69
n
69
LYS
69
A
THR
70
n
70
THR
70
A
PRO
71
n
71
PRO
71
A
GLY
72
n
72
GLY
72
A
ALA
73
n
73
ALA
73
A
VAL
74
n
74
VAL
74
A
ASN
75
n
75
ASN
75
A
ALA
76
n
76
ALA
76
A
CYS
77
n
77
CYS
77
A
HIS
78
n
78
HIS
78
A
LEU
79
n
79
LEU
79
A
SER
80
n
80
SER
80
A
CYS
81
n
81
CYS
81
A
SER
82
n
82
SER
82
A
ALA
83
n
83
ALA
83
A
LEU
84
n
84
LEU
84
A
LEU
85
n
85
LEU
85
A
GLN
86
n
86
GLN
86
A
ASP
87
n
87
ASP
87
A
ASN
88
n
88
ASN
88
A
ILE
89
n
89
ILE
89
A
ALA
90
n
90
ALA
90
A
ASP
91
n
91
ASP
91
A
ALA
92
n
92
ALA
92
A
VAL
93
n
93
VAL
93
A
ALA
94
n
94
ALA
94
A
CYS
95
n
95
CYS
95
A
ALA
96
n
96
ALA
96
A
LYS
97
n
97
LYS
97
A
ARG
98
n
98
ARG
98
A
VAL
99
n
99
VAL
99
A
VAL
100
n
100
VAL
100
A
ARG
101
n
101
ARG
101
A
ASP
102
n
102
ASP
102
A
PRO
103
n
103
PRO
103
A
GLN
104
n
104
GLN
104
A
GLY
105
n
105
GLY
105
A
ILE
106
n
106
ILE
106
A
ARG
107
n
107
ARG
107
A
ALA
108
n
108
ALA
108
A
TRP
109
n
109
TRP
109
A
PRO
110
n
110
PRO
110
A
ALA
111
n
111
ALA
111
A
TRP
112
n
112
TRP
112
A
ARG
113
n
113
ARG
113
A
ASN
114
n
114
ASN
114
A
ARG
115
n
115
ARG
115
A
CYS
116
n
116
CYS
116
A
GLN
117
n
117
GLN
117
A
ASN
118
n
118
ASN
118
A
ARG
119
n
119
ARG
119
A
ASP
120
n
120
ASP
120
A
VAL
121
n
121
VAL
121
A
ARG
122
n
122
ARG
122
A
GLN
123
n
123
GLN
123
A
TYR
124
n
124
TYR
124
A
VAL
125
n
125
VAL
125
A
GLN
126
n
126
GLN
126
A
GLY
127
n
127
GLY
127
A
CYS
128
n
128
CYS
128
A
GLY
129
n
129
GLY
129
A
VAL
130
n
130
VAL
130
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LYS
1
A
O
LYS
1
A
N
THR
40
A
N
THR
40
A
O
ALA
42
A
O
ALA
42
A
N
GLY
55
A
N
GLY
55
A
O
THR
52
A
O
THR
52
A
N
SER
61
A
N
SER
61
1
-4.25
0.50
120.30
116.05
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
14
14
14
N
1
-4.16
0.50
120.30
116.14
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
21
21
21
N
1
16.96
2.60
111.60
128.56
A
A
A
CB
CG
CD
ARG
ARG
ARG
41
41
41
N
1
14.89
1.40
123.60
138.49
A
A
A
CD
NE
CZ
ARG
ARG
ARG
41
41
41
N
1
3.62
0.50
120.30
123.92
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
41
41
41
N
1
-5.85
0.90
118.30
112.45
A
A
A
CB
CG
OD2
ASP
ASP
ASP
49
49
49
N
1
42.32
1.40
123.60
165.92
A
A
A
CD
NE
CZ
ARG
ARG
ARG
50
50
50
N
1
4.66
0.50
120.30
124.96
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
50
50
50
N
1
-7.51
0.90
118.30
110.79
A
A
A
CB
CG
OD2
ASP
ASP
ASP
53
53
53
N
1
9.53
0.90
118.30
127.83
A
A
A
CB
CG
OD1
ASP
ASP
ASP
87
87
87
N
1
-7.52
0.90
118.30
110.78
A
A
A
CB
CG
OD2
ASP
ASP
ASP
87
87
87
N
1
3.46
0.50
120.30
123.76
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
98
98
98
N
1
4.40
0.50
120.30
124.70
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
101
101
101
N
1
10.31
1.40
123.60
133.91
A
A
A
CD
NE
CZ
ARG
ARG
ARG
113
113
113
N
1
5.23
0.50
120.30
125.53
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
113
113
113
N
1
17.02
2.10
111.80
128.82
A
A
A
CG
CD
NE
ARG
ARG
ARG
115
115
115
N
1
26.38
1.40
123.60
149.98
A
A
A
CD
NE
CZ
ARG
ARG
ARG
115
115
115
N
1
-3.40
0.50
120.30
116.90
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
115
115
115
N
1
9.80
0.50
120.30
130.10
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
115
115
115
N
1
-5.82
0.90
118.30
112.48
A
A
A
CB
CG
OD2
ASP
ASP
ASP
120
120
120
N
1
12.52
1.40
123.60
136.12
A
A
A
CD
NE
CZ
ARG
ARG
ARG
122
122
122
N
1
5.18
0.50
120.30
125.48
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
122
122
122
N
1
A
A
O
O
HOH
HOH
168
183
1.08
1_555
2_565
1
A
A
NH1
O
ARG
HOH
21
202
1.99
1_555
4_557
0.16
1.8
5.0
10232
1
1.8
5.0
101
1130
0
0
1029
0.016
refinement
PROLSQ
LYSOZYME (E.C.3.2.1.17) MUTANT WITH VAL 110 REPLACED BY PRO (V110P)
ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS
1
N
N
2
N
N
A
ARG
5
A
ARG
5
HELX_P
A
ARG
14
A
ARG
14
1
A
10
A
LEU
25
A
LEU
25
HELX_P
A
GLU
35
A
GLU
35
1
B
11
A
SER
80
A
SER
80
HELX_P
A
LEU
85
A
LEU
85
5
E
6
A
ALA
90
A
ALA
90
HELX_P
A
VAL
99
A
VAL
99
1
C
10
A
PRO
110
A
PRO
110
HELX_P
A
CYS
116
A
CYS
116
1
D
7
disulf
2.014
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
128
A
SG
CYS
128
1_555
disulf
2.049
A
CYS
30
A
SG
CYS
30
1_555
A
CYS
116
A
SG
CYS
116
1_555
disulf
2.004
A
CYS
65
A
SG
CYS
65
1_555
A
CYS
81
A
SG
CYS
81
1_555
disulf
2.023
A
CYS
77
A
SG
CYS
77
1_555
A
CYS
95
A
SG
CYS
95
1_555
HYDROLASE(O-GLYCOSYL)
HYDROLASE(O-GLYCOSYL)
LYSC_HUMAN
UNP
1
1
P61626
MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSR
YWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV
19
148
1LHH
1
130
P61626
A
1
1
130
1
VAL
CONFLICT
PRO
110
1LHH
A
P61626
UNP
128
110
2
3
anti-parallel
anti-parallel
anti-parallel
A
LYS
1
A
LYS
1
A
PHE
3
A
PHE
3
A
TYR
38
A
TYR
38
A
THR
40
A
THR
40
A
ALA
42
A
ALA
42
A
ASN
46
A
ASN
46
A
SER
51
A
SER
51
A
GLY
55
A
GLY
55
A
ILE
59
A
ILE
59
A
SER
61
A
SER
61
19
P 21 21 21